|
|
Dr Jeroen Aerssens,
Head Translational Genomics & Genetics, European Discovery Capabilities, Tibotec BVBA - Johnson & Johnson
|
 |
|
|
Dr Roman Artymyshyn,
Principal Scientist, Target Discovery and Assessment, Lundbeck Research
|
|
|
|
Mirco Castoldi,
Postdoctoral Fellow, Hentze Group, EMBL Heidelberg, Germany
|
|
|
|
Dr. Raffaele Di Francia,
Lab of Molecular Hematology, Institute of Tumors G. Pascale
|
|
|
|
Benaissa El-Moualij,
Center of Immunology, Institute of Pathology, University of Liege
|
|
|
|
Dr Olivier Grenet,
Group Head Genome Biology, Investigative Toxicology, Translational Sciences, Novartis Pharma
|
|
|
|
Susanne Heinsohn,
University Hospital Hamburg-Eppendorf, Clinic for Hematology and Oncology, Germany
|
|
|
|
Jean-Luc Henrioul,
Commercial and Business Development Director, BioXpr
|
|
|
|
Stig Ove Hjelmevoll,
Scientist, Department of Microbiology and Infection Control, University Hospital of North Norway
|
|
|
|
Sami Hokkanen,
Senior Biostatician, Research & Translational Statistics, Biostatistics & Support Functions, R&D, Orion Pharma
|
|
|
|
Nana Jacobsen,
Senior Scientist, Exiqon
|
|
|
|
Ian Kavanagh,
Research and Develoment Manager, Thermo Scientific Genomics
|
|
|
|
Hansjoerg Keller,
Senior Research Investigator, Novartis
|
|
|
|
Dr Gustavo H. Kijak,
Chief of Section Host Genetics, Military HIV Program, Henry M Jackson Foundation
|
|
|
|
Dr. Jan Kristek,
Director and Head of Immunological Department, Karlovarske Imunologicke Centrum
|
|
|
|
Paul E. Kroeger,
Senior Group Leader GPRD, Neuroscience & Pain Discovery, Abbott Laboratories
|
|
|
|
Prof. Michael Kubista,
Head Laboratoř genové exprese, Biotechnologický ústav AV ČR
|
|
|
|
Dr Viktor Lakics,
Senior Research Scientist - Neurodegeneration DHT, Eli Lilly
|
|
|
|
Ralf Mauritz,
Director, R&D, Roche Diagnostics GmbH
|
|
|
|
Patricia McLoughlin,
Head of Genomics, F. Hoffmann-La Roche Ltd
|
|
|
|
Afif Abdel Nour,
Research Scientist, Molecular Biotechnology, Institut Polytechnique LaSalle Beauvais
|
|
|
|
Dr Veronika Okršlar,
Biopharmaceuticals, Cell and Molecular Biology, Lek Pharmaceuticals d.d.a. Sandoz Company
|
|
|
|
Prof. Claudio Orlando,
Professor, Clinical Biochemistry Unit, Department of Clinical Physiopathology, University of Florence
|
|
|
|
Dr Natasha Paul,
Senior Staff Scientist, TriLink Biotechnologies
|
|
|
|
Senior Representative,
Qiagen
|
|
|
|
Dr. Jan M. Ruijter,
Department of Anatomy and Embryology, Academic Medical Centre, Amsterdam
|
|
|
|
Dr Chaminda Salgado,
Head of PCR Services, Pharmaceutical Analysis, NDA Analytics
|
|
|
|
Mathias Schmidt,
Associate Principal, Strategic Planning and Business Support, Nycomed GmbH
|
|
|
|
Dr Andrej-Nikolai Speiss,
Department of Andrology, University Hospital Hamburg-Eppendorf
|
|
|
|
Rolf Studer,
Senior Lab Head, Actelion
|
|
|
|
Dr Marco Tomasetti,
Department of Molecular Pathology and Innovative Therapies, Polytechnic University of Marche, Italy
|
|
|
|
Emiliano Toso
Head of the Molecular Biology Laboratory RBM Merk Serono
|
|
|
|
Thorsten Traeger,
Project Manager, R&D, Qiagen
|
|
|
|
Dr Ales Trichopad,
Co Founder and CTO, Labonnet
|
|
|
|
Victor Turcanu,
Lecturer in Paediatric Allergy, Division of Asthma, Allergy and Lung Biology, King's College London
|
|
|
|
Dr Dan Turner,
Head of Sequencing Technology, Wellcome Trust Sanger Institute
|
|
|
|
Andreas Weinhausel,
Senior Scientist, Molecular Diagnostics, Austrian Research Centers ARC
|
|
|
|
Dr Jo Woods,
Senior Research Scientist, MedImmune
|
|
|
|
Neven Zoric,
CEO, TATAA Biocenter
|
|
